Full Spectrum Boswellia Double Strength

Full Spectrum Boswellia Double Strength

Swanson4.8 (11,559 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals
$11.09 $0.18 per serving

About this product

The 800 mg serving supplies a substantial amount of Boswellia serrata. Its single-ingredient design is easy to understand and directly relevant to joint-comfort and inflammatory-balance goals.

Whole-herb weight cannot be compared directly with a concentrated standardized extract. No boswellic-acid percentage, AKBA level, or extraction ratio is supplied, so the effective active dose remains uncertain.

A low ongoing cost makes experimentation less expensive, and one capsule per serving keeps use simple. It best fits budget-led buyers who accept less predictable potency in exchange for a large raw-herb amount.

Who is it for
  • Budget-conscious adults seeking basic Boswellia
  • People who prefer a whole-herb formula
  • Users comfortable with uncertain active-marker levels
Best for
  • Low-cost Boswellia supplementation
  • Simple single-ingredient use
  • People who prioritize raw-herb amount

Pros

  • Large 800 mg herb serving
  • Focused single-ingredient formula
  • Very favorable ongoing cost

Cons

  • Not identified as a standardized extract
  • No boswellic-acid or AKBA amounts
  • No stated absorption support

Warnings

  • Boswellia may cause nausea, abdominal discomfort, or loose stools.
  • Boswellia can add to anticoagulant or antiplatelet effects.
  • A high raw-herb amount may be harder to tolerate than a smaller concentrated extract.

Product analysis

78 out of 100
An inexpensive, large whole-herb serving is easy to use, but its active potency is far less certain than a standardized extract.

AI assessment of the formula, label and price. How scoring works

Nutrient quality76

The large whole-herb amount is directly relevant and reaches a useful basic range. Missing active-acid standardization and absorption support make potency unpredictable.

.
Ingredient transparency75

The herb amount is disclosed without a hidden blend. Intake directions, inactive ingredients, and active-compound strength are not supplied.

.
Customer satisfaction73

The supplied average rating is strong and comes from a very large rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.
Value for money91

The large herb amount and low serving cost create good basic value. Missing standardization keeps the product from competing on quality.

.
Format
Capsule
Container
60 Capsule(s)
Per serving
$0.18
Customer rating
4.8 · 11,559 ratings
Report analysis

Goals

Anti-Inflammatory Support
Impact
Limited evidence
F Ingredient FitF PathwaysF EvidenceF Formulation Logic
Boswellia · 800 mg
Study evidence
Boswellia Supportive 19 studies
Joint Health
Impact
Moderate effect
A+ Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Boswellia · 800 mg
Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per servingScore
Boswellia serrata
800 mg 30
Adults 18–50
Report overview
Boswellia · 800 mg OverallScore30
F Composition And Label DisclosureC Composition And Label Disclosure
Full Spectrum Boswellia Double Strength provides 800 mg of Boswellia serrata per serving, but no boswellic-acid percentage is recorded. The amount is clear, while the marker amount remains unknown. No Boswellia-specific price comparison is provided.
How this ingredient is rated

Composition and Label Disclosure0

The saved details identify Boswellia serrata but give no boswellic-acid percentage.
Marker and Preparation Disclosure
Boswellia serrata is named, but no boswellic-acid percentage is recorded.

Composition and Label Disclosure60

The serving amount is known, but the saved information gives no marker percentage.
Boswellia Amount and Marker Disclosure
The product states 800 mg of Boswellia, but gives no associated marker percentage.

Commercial Price and Usability

No Boswellia-specific price comparison is provided here.
Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
    Dalmonte T; Andreani G; Rudelli C; Isani G · Phytotherapy research : PTR · 2024
    Meta-analysis1,185 participants13 studies pooledJoint Health forBoswellia
  2. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  3. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.
    Kulkarni PD; Damle ND; Singh S; Yadav KS; Ghante MR; Bhaskar VH; Hingorani L; Gota VS · Drug metabolism and personalized therapy · 2021
    Randomized trialAnti-Inflammatory Support forBoswellia
  4. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsJoint Health Anti-Inflammatory Support forBoswellia
  5. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsJoint Health Anti-Inflammatory Support forBoswellia
  6. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  7. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  8. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support Joint Health forBoswellia
  9. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health Anti-Inflammatory Support forBoswellia
  10. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  11. Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study.
    Karlapudi V; Sunkara KB; Konda PR; Sarma KV; Rokkam MP · Journal of the American Nutrition Association · 2023
    Randomized trial70 participantsJoint Health forBoswellia
  12. Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis.
    Zhang Y; Gui Y; Adams R; Farragher J; Itsiopoulos C; Bow K; Cai M; Han J · Nutrients · 2025
    Meta-analysis4,599 participants39 studies pooledJoint Health forBoswellia
  13. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis.
    Bannuru RR; Osani MC; Al-Eid F; Wang C · Seminars in arthritis and rheumatism · 2019
    Meta-analysis1,009 participants11 studies pooledJoint Health forBoswellia
  14. A full-spectrum Boswellia serrata extract with enhanced bioavailability, and its co-delivered system with curcumin alleviate pain and stiffness associated with moderate spondylitis: a randomized double-blind, placebo-controlled, 3-arm study.
    Mamatha K; Prabhakaran P; Syam Das S; Kanjoormana Aryan M; Thomas J · Frontiers in pharmacology · 2025
    Randomized trial105 participantsAnti-Inflammatory Support forBoswellia
  15. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.
    Sengupta K; Krishnaraju AV; Vishal AA; Mishra A; Trimurtulu G; Sarma KV; Raychaudhuri SK; Raychaudhuri SP · International journal of medical sciences · 2011
    Randomized trial60 participantsJoint Health forBoswellia
  16. Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities.
    Efferth T; Oesch F · Seminars in cancer biology · 2022
    Systematic reviewAnti-Inflammatory Support forBoswellia
  17. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia